News
    RAIsonance Submits EUA Application to FDA for AudibleHealth Dx
    RAIsonance, Inc., today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its AudibleHealth Dx Software as a Medical Device (SaMD). The device is designed to analyze a user’s Forced Coug...

    26 September 2022

    read more...
    News
    RAIsonance Appoints Rudy Karsan as Chairman of the Board
    RAIsonance, Inc., a group of AI-powered technology solutions companies that is revolutionizing the COVID-19 testing space and helping to meet today’s critical global health challenges, is proud to announce the appointment of Rudy Karsan as its new Chairman of the Board....

    10 June 2022

    read more...
    News
    RAIsonance Empowers Businesses and Consumers with SoundPass Technology
    RAIsonance, Inc., a family of Artificial Intelligence/Machine Learning (AI/ML)-based technology companies headquartered in the Denver Tech Center, announced the launch of one of its newest and most innovative products, SoundPass.

    5 August 2021

    read more...
    News
    RAIsonance, Inc. Announces First Medical Advisory Board
    AI Technology Company Brings Together Revered Team of Healthcare Professionals from Around the Country

    2 July 2021

    read more...
    News
    RAIsonance, Inc. Joins Microsoft for Startups Program
    RAIsonance Selected for Microsoft for Startups Program Designed to Help the World’s Most Promising B2B Startups Quickly Scale

    1 July 2021

    read more...
    1
    2